Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alitretinoin in Cutaneous Lupus Erythematosus
NCT01407679Phase 2Terminated
- Sponsor
- Universitätsklinikum Münster
- Start
- Aug 2011
- Primary completion
- Apr 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of alitretinoin in cutaneous lupus erythematosus (CLE), sponsored by Universitätsklinikum Münster. Started Aug 2011; status: terminated.
02
Drugs
alitretinoin
03
Conditions
cutaneous lupus erythematosus (CLE)
Beyond the preview
Go deeper on NCT01407679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01407679.